DETERMAIO Trademark
Trademark Overview
On Friday, July 28, 2023, a trademark application was filed for DETERMAIO with the United States Patent and Trademark Office. The USPTO has given the DETERMAIO trademark a serial number of 98107390. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, February 6, 2025. This trademark is owned by Oncocyte Corporation. The DETERMAIO trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Providing reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of evaluating patient immunotherapy cancer treatment options
General Information
| Serial Number | 98107390 |
| Word Mark | DETERMAIO |
| Filing Date | Friday, July 28, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, February 6, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 11, 2024 |
Trademark Statements
| Goods and Services | Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient |
| Goods and Services | Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use |
| Goods and Services | Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use |
| Goods and Services | Providing reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of evaluating patient immunotherapy cancer treatment options |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Oncocyte Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Party Name | Oncocyte Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 1, 2023 | NEW APPLICATION ENTERED |
| Monday, August 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Monday, April 1, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, April 1, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, April 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 22, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 11, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 11, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 6, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 6, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 6, 2025 | SOU EXTENSION 1 FILED |
| Thursday, February 6, 2025 | SOU EXTENSION 1 GRANTED |
| Friday, February 7, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 6, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, December 22, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
